Long-term bevacizumab is safe and effective in managing small bowel angioectasias bleeding refractory to conventional treatments: a case report
- PMID: 38974879
- PMCID: PMC11227363
- DOI: 10.1093/gastro/goae070
Long-term bevacizumab is safe and effective in managing small bowel angioectasias bleeding refractory to conventional treatments: a case report
Conflict of interest statement
None to declare for all authors. Figure 1.Mean Hb levels during the observation period. The grey thinner box corresponds to the lower dose of bevacizumab. Hb = haemoglobin, BVZ = bevacizumab.
Figures
Similar articles
-
Small Intestinal Angioectasias Are Not Randomly Distributed in the Small Bowel and Most May Be Reached by Push Enteroscopy.J Clin Gastroenterol. 2016 Aug;50(7):561-5. doi: 10.1097/MCG.0000000000000425. J Clin Gastroenterol. 2016. PMID: 26485105
-
High short-term rebleeding rate in patients undergoing a second endoscopic therapy for small-bowel angioectasias after recurrent bleeding.Rev Esp Enferm Dig. 2018 Feb;110(2):88-93. doi: 10.17235/reed.2017.4872/2017. Rev Esp Enferm Dig. 2018. PMID: 29152987
-
Predictors and characteristics of angioectasias in patients with obscure gastrointestinal bleeding identified by video capsule endoscopy.United European Gastroenterol J. 2017 Dec;5(8):1129-1135. doi: 10.1177/2050640617704366. Epub 2017 Apr 7. United European Gastroenterol J. 2017. PMID: 29238592 Free PMC article.
-
Management of small bowel angioectasias diagnosed during video capsule endoscopy.Ann Gastroenterol. 2023 Mar-Apr;36(2):103-113. doi: 10.20524/aog.2023.0780. Epub 2023 Feb 3. Ann Gastroenterol. 2023. PMID: 36864941 Free PMC article. Review.
-
Overview of small bowel angioectasias: clinical presentation and treatment options.Expert Rev Gastroenterol Hepatol. 2018 Feb;12(2):125-139. doi: 10.1080/17474124.2018.1390429. Epub 2017 Oct 18. Expert Rev Gastroenterol Hepatol. 2018. PMID: 28994309 Review.
References
-
- Holleran G, Hall B, Zgaga L. et al. The natural history of small bowel angiodysplasia. Scand J Gastroenterol 2016;51:393–9. - PubMed
-
- Lanas A, García-Rodríguez LA, Polo-Tomás M. et al. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther 2011;33:585–91. - PubMed
-
- Nardone G, Compare D, Martino A. et al. Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: A position paper of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 2018;50:542–8. - PubMed
-
- Albitar HAH, Almodallal Y, Papadakis KA. et al. Intravenous bevacizumab reduces transfusion requirements and endoscopic interventions in patients with gastric antral vascular ectasia and small bowel angioectasia. Gastroenterology 2020;158:1162–3.e4. - PubMed
LinkOut - more resources
Full Text Sources